Iva
Iva Cermakova US
Patent application number | Description | Published |
---|---|---|
20150297083 | ELASTOGRAPHY DEVICE AND METHOD FOR OPERATING IT - The invention relates, inter alia, to a method for operating an elastography device ( | 10-22-2015 |
Iva Chianella, Silsoe GB
Patent application number | Description | Published |
---|---|---|
20080311072 | Preparation of Soluble and Colloidal Molecularly Imprinted Polymers by Living Polymerization - The present invention describes a method for synthesis of relatively low molecular weight imprinted polymers using living polymerization, and their application in analytical chemistry, pharmacology, medicine and the food industry. Specifically the low-molecular weight polymers are synthesized by the polymerization of functional monomers in the presence of a template, such as a biological receptor, enzyme, nucleic acid, cell, virus, microorganism, tissue sample or drug using living initiator. The conditions of living polymerization ensure a relatively small size of synthesized molecules. Synthesized in this way molecules (dimers, oligomers, polymers, or their mixture) have a higher affinity to the template than the original monomers and can rebind it in vitro and/or in vivo. As a further aspect of the present invention, polymers synthesized as described above can be used as drugs in pharmacology and medicine, as receptor-specific ligands in analytical chemistry (sensors, assays), and for separations in the biotechnology, pharmaceutical and food industries. | 12-18-2008 |
Iva Chianella, Bedfordshire GB
Patent application number | Description | Published |
---|---|---|
20110111350 | Conjugated Polymers - A monomer M-S has a first polymerisable moiety (M) capable of forming a conjugated polymer, and a second polymerisable moiety (S) with a double bond susceptible to addition polymerisation. Polymerisation of the M-moieties is caused, generally by electropolymerisation or chemical oxidation. Polymerisation of the S-moieties is also caused, generally by a radical mechanism, before, after or simultaneously with the M-polymerisation. Suitable monomers include N-(methacrylamidoethyl)-aniline, N-(acrylamidoethyl)-aniline, N-(methacryloyloxyethyl)-aniline and N-(acryloyloxyethyl)-aniline. | 05-12-2011 |
Iva Franjkic, League City, TX US
Patent application number | Description | Published |
---|---|---|
20120238785 | Process For The Production of Ethanol From An Acetic Acid Feed and A Recycled Ethyl Acetate Feed - The present invention produces ethanol in a reactor that comprises a catalyst composition and a feed stream comprising acetic acid and a recycled liquid stream comprising ethyl acetate. The catalyst composition comprises a first catalyst comprising platinum, cobalt, and/or tin and a second catalyst comprising copper. The crude ethanol product may be separated and ethanol recovered. | 09-20-2012 |
20130131400 | Hydrogenating Acetic Acid to Produce Ethyl Acetate and Reducing Ethyl Acetate to Ethanol - Disclosed herein are processes for alcohol production by reducing an ethyl acetate produced by hydrogenating acetic acid in the presence of a suitable catalyst. The ethyl acetate is reduced with hydrogen in the presence of a catalyst to obtain a crude reaction mixture comprising the alcohol, in particular ethanol, which may be separated from the crude reaction mixture. Thus, ethanol may be produced from acetic acid through an ethyl acetate intermediate without an esterification step. This may reduce the recycle of ethanol in the hydrogenolysis process and improve ethanol productivity. | 05-23-2013 |
20130158297 | ESTERIFYING AN ETHANOL AND ACETIC ACID MIXTURE TO PRODUCE AN ESTER FEED FOR HYDROGENOLYSIS - Disclosed herein are processes for alcohol production by hydrogenating acetic acid to obtain a mixture of ethanol and acetic acid, esterifying the mixture to produce an esterification product and reducing the esterification product. The mixture may provide a sufficient amount of ethanol and acetic acid for esterification and reduces the need for additional acetic acid and/or ethanol. This may reduce the recycle of ethanol in the hydrogenolysis process and improve ethanol productivity. | 06-20-2013 |
20150133700 | Process for Producing Ethanol by Hydrogenation with Carbon Monoxide Controls - A process for produce ethanol by hydrogenation acetic acid and/or esters thereof is disclosed. The process involves reacting hydrogen feed stream with an acetic acid feed stream in a reactor operated in the presence of a catalyst to form an ethanol mixture and monitoring carbon monoxide concentration of the fresh hydrogen feed stream and adjusting temperature in the reactor in response to the carbon monoxide concentration of the fresh hydrogen feed stream. | 05-14-2015 |
Iva Segalman, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20130263857 | MECHANICAL VENTILATION MASK FIT STATUS INDICATION - Indicating fit status of a mask in communication with a respiratory assistance device is disclosed. Upon initiating a therapeutic gas delivery from the respiratory assistance device to the mask, one or more measurements from respective one or more sensors of the respiratory assistance device is received. A leakage value from these measurements is derived, and a mask fit index is assigned. This is based at least upon a correlation of the leakage value to a particular sub-range of predetermined leakage values that corresponds to the mask fit index. The particular sub-range of predetermined leakage values is one among a plurality of sub-ranges, which together comprises an overall mask fit range defined at least by an ideal mask fit region, a loose mask fit region, and a tight mask fit region. A mask fit status based upon the assigned mask fit index is output to an indicator interface. | 10-10-2013 |
20130333702 | METHOD AND SYSTEM FOR OPERATING A PATIENT VENTILATION DEVICE - A patient ventilation system including a ventilation interface and a ventilation source pneumatically coupled to a patient over the ventilation interface is disclosed. There is a controller that regulates airflow delivery from the ventilation source to the patient according to one or more predefined treatment configuration settings. The controller has an inactive ventilation state, a ventilation initiation state, a treatment state, a treatment suspension state, and a ventilation deactivation state. A display interface is coupled to the controller and configured to generate, exclusively, a device activation user element with the pressure controller in the inactive ventilation state, a fitment feedback indicator and a treatment screen in a ventilation initiation state, the fitment feedback indicator and a treatment status screen in the treatment state, a treatment suspension screen in the treatment suspension state, and a treatment conclusion screen in the ventilation deactivation state. | 12-19-2013 |
Iva Segalman, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20150199024 | Systems and Methods for User Generated Content Authoring - Systems and methods for user generated content authoring are disclosed. One illustrative method disclosure herein includes: receiving a video signal; displaying a user interface associated with haptic authoring; detecting a gesture associated with a haptic effect; determining a haptic effect based in part on the gesture; associating the haptic effect with a location in the video signal; and storing the video signal and the associated haptic effect. | 07-16-2015 |
Iva Shallvari, Troy, MI US
Patent application number | Description | Published |
---|---|---|
20130338863 | HYBRID VEHICLE CONTROL - A method and powertrain apparatus for controlling a hybrid electric vehicle powertrain to maintain a catalyst within a catalytic converter at an efficient operating temperature while also maximizing the use of electric vehicle operating mode. The method and apparatus determine, during an electric vehicle operating mode, whether a catalyst efficiency is below a predetermined threshold and, if it is determined that the catalyst efficiency is below the predetermined threshold, suspend the electric vehicle operating mode and turn on the vehicle's engine to bring the catalyst efficiency to or above the predetermined threshold. | 12-19-2013 |
20130338864 | HYBRID VEHICLE CONTROL - A method and apparatus for heating a catalytic converter's catalyst to an efficient operating temperature in a hybrid electric vehicle when the vehicle is in a charge limited mode such as e.g., the charge depleting mode or when the vehicle's high voltage battery is otherwise charge limited. The method and apparatus determine whether a high voltage battery of the vehicle is incapable of accepting a first amount of charge associated with a first procedure to warm-up the catalyst. If it is determined that the high voltage battery is incapable of accepting the first amount of charge, a second procedure with an acceptable amount of charge is performed to warm-up the catalyst. | 12-19-2013 |
Iva Truxova, Olomouc CZ
Patent application number | Description | Published |
---|---|---|
20150184130 | CRYOPRESERVATION OF APOPTOTIC CANCER CELLS FOR USE IN IMMUNOTHERAPY AGAINST CANCER - Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer. | 07-02-2015 |
Iva Tunjic, Zagreb HR
Patent application number | Description | Published |
---|---|---|
20090137613 | PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS - The present invention is concerned with new pharmaceutically acceptable salts of valacyclovir, polymorphic forms, processes for preparing the new pharmaceutically acceptable salts and new polymorphic forms, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same. | 05-28-2009 |
20110184030 | Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate - The present invention is concerned with new polymorphic forms of flupirtine maleate, processes for preparing the new polymorphic forms, pharmaceutical compositions containing them, therapeutic uses thereof and methods of treatment employing them. | 07-28-2011 |
20120142743 | PHARMACEUTICALLY ACCEPTABLE SALT AND POLYMORPHIC FORMS OF FLUPIRTINE MALEATE - New polymorphic forms of flupirtine maleate are described. | 06-07-2012 |
20130065888 | OPHTHALMIC FORMULATIONS AND PROCESSES FOR THEIR PREPARATION - The invention relates to a process for preparing ophthalmic formulations and to formulations containing a suspension of an ophthalmic drug in an aqueous vehicle. The invention further relates to the production of stable ophthalmic formulations that have a minimal propensity to form drug aggregates. | 03-14-2013 |